Pharmaron is a leading global contract research organization (CRO) headquartered in the United States, with offices and facilities in both the US and China. The company specializes in drug discovery and development services, offering a wide range of solutions to support the pharmaceutical and biotech industries. Founded in 2003, Pharmaron has rapidly grown to become one of the largest CROs in the world.

It started as a small chemistry-based business in Beijing, China, focusing on providing chemistry research services. Over the years, it expanded its capabilities and service offerings through acquisitions and organic growth. In 2007, Pharmaron opened its first US location in North Carolina, and since then, it has continued to expand its presence in both the United States and China.

Pharmaron's headquarters is located in Research Triangle Park, North Carolina, a renowned hub for scientific research and development. The facility spans over 260,000 square feet and houses state-of-the-art laboratories, cutting-edge technologies, and a pool of talented scientists and researchers. The company's main products and services include the discovery chemistry and biology, pharmaceutical development, bioanalytical services, and drug metabolism and pharmacokinetics (DMPK) services.

Pharmaron offers integrated services throughout the drug discovery and development process, from hit identification to preclinical development and beyond. It collaborates with pharmaceutical and biotech companies globally to advance their drug candidates towards commercialization. Pharmaron operates on a global scale, with a significant presence in China and the United States.

It has several subsidiaries and partnerships that further expand its capabilities and geographic reach. Some of its notable subsidiaries include Quotient Sciences, Xceleron, and Allergan Biologics. Pharmaron also has strategic partnerships and collaborations with industry-leading organizations, leveraging their collective expertise to drive innovation in drug discovery and development.

In terms of market position, Pharmaron is a major player in the CRO industry, with a strong global presence. It has strategically positioned itself as a comprehensive drug R&D service provider, catering to the evolving needs of the pharmaceutical and biotech sectors. With a diverse range of services and a reputation for delivering high-quality results, Pharmaron has earned the trust of its clients and established itself as a trusted partner in drug discovery and development.

In recent years, Pharmaron has achieved several milestones and made significant strategic moves to support its growth. For example, in 2019, it acquired Quotient Sciences, a UK-based pharmaceutical development and manufacturing organization, to expand its global capabilities and enhance its integrated drug development solutions. As of the latest updates, Pharmaron continues to innovate and expand its service offerings.

The company remains committed to providing exceptional scientific expertise and enabling its clients to expedite the development of safe and effective therapeutics. With its strong market presence, global reach, and commitment to excellence, Pharmaron is poised for further growth and success in the dynamic pharmaceutical industry